My Blog Of Knowledge: Pfizer Issues Voluntary Recall of Citalopram and Finasteride

By Psych Central News Editor
Reviewed by John M. Grohol, Psy.D.on March 28, 2011

The maker of Citalopram and Finasteride announced a voluntary recall of the two drugs Saturday due to mislabeling and possible ingestion of the wrong drug by patients.

Greenstone LLC, a subsidiary of drug giant Pfizer, announced that it is voluntarily conducting a recall, to the patient level, of medicines with lot number FI0510058-A on the label. This includes Citalopram 10mg Tablets (100-count bottle) and Finasteride 5mg Tablets (90-count bottle), both distributed in the U.S. market.

The recall is due to the possibility that incorrect labels have been placed on the bottles by a third-party manufacturer. This is the only lot number being recalled and no other lots or markets are believed to be impacted.

Importantly, bottles labeled as Citalopram Lot # FI0510058-A may contain Finasteride. Patients who believe they may have ingested the wrong medication should contact their physician as soon as possible.

Women who are, or may become pregnant, should not take or handle Finasteride due to the possible risk of side effects which may cause abnormalities to the external genitalia of a developing male fetus. Citalopram is not recommended for patients taking monoamine oxidase inhibitors (MAOIs) or pimozide, It is also not recommended for patients with a hypersensitivity to Citalopram or any of the inactive ingredients in the tablet. Patients who discontinue Citalopram abruptly by inadvertently taking the mislabeled product may experience discontinuation symptoms and/or worsening of depression.

Bottles of either Citalopram (used to treat depression) or Finasteride (for the treatment of benign prostatic hyperplasia) with lot number FI050058-A should be returned to the pharmacist.

Consumers should contact their physician or health care provider if they have experienced any problems that may be related to taking or using this product. Also, any adverse events that may be related to the use of these products should be reported to Pfizer Inc. at-1-800-438-1985 (24 hours a day) or to FDA’s Med Watch Program either online, by regular mail or by fax (1-800-FDA-0178).

Regular Mail: Use postage-paid, pre-addressed Form FDA 3500. Mail to the address on the pre-addressed form.

Related News Articles
Fear of Side Effects Prompts Many Seniors to Forgo Heart MedsEvidence for Atypical Antipsychotic Drugs Called into QuestionTeens with Hard-to-Treat Depression at High Risk for RelapsePostpartum Depression Can Be Serious Early Meds, Counseling Aid Schizophrenia Eating Disorders Linked to Self HarmFirst ADHD Add-On Drug ApprovedDespite Guidelines, Antidepressants Prescribed During Mania EpisodesHallucinogens Show Promise for Anxiety PatientsCombination Treatment Best for Early Schizophrenia

Depression, FDA Alert, General, Medications -->

NewsAddictionADHDAdvocacy and PolicyAggression and ViolenceAgingAgoraphobiaAlcoholismAlzheimer'sAnorexiaAnxietyAutismBipolarBlogrollBrain and BehaviorBulimiaChildren and TeensDepressionDissociationDomestic ViolenceEating DisordersFDA AlertFeaturedGeneralGeneticsHealth-relatedLifeHelperMedicationsMemory and PerceptionMental Health and WellnessNeuropsychology and NeurologyOCDpainPanic DisorderParentingParkinson'sPersonalityPhobiasPoliticsProfessionalPsoriasisPsychologyPsychotherapyPTSDRelationships and SexualityResearchSchizophreniaSleepSocial PhobiaStressStudentsSubstance AbuseSuicideTechnologyWork and Career

ArchivesMarch 2011February 2011January 2011December 2010November 2010October 2010September 2010August 2010July 2010June 2010May 2010April 2010200820072006Older News Stumble This Article Print Email From Our News Bureau Adolescent Brain Development Tied to Resisting Peer Pressure Twin Studies Suggest Genetic Risk for Panic Disorder
Just Published...I Don’t Want To Be A Super Hero Right... Mental Power is Disproving Darwin’s Theory of Survival of... Equine Therapy: What Every Treatment Center Needs To Know...
What's Hot3 Lessons Learned From Studying SuccessadvertisementMost Popular News Adolescent Brain Development Tied to Resisting Peer Pressure Twin Studies Suggest Genetic Risk for Panic Disorder Psychiatric Problems With Epilepsy Impacted by Gender Spirituality Speeds Recovery from Collective Trauma Psychiatric Drug Errors Reduced Through Computerized System Religious Young Adults More Likely to Become Obese by Middle Age Personality Traits Drive Choices in Entertainment Missed Sleep Jolts Mood, Impairs Decision-Making Training To Rewire Brain Offers Hope for Alzheimer's Most Popular Blog PostsPediatrics Gets it Wrong about 'Facebook Depression' Free Webinar on Social Media and Relationships, April 4th 7 Reasons Charlie Sheen May Hate Alcoholics Anonymous Delusions Keep Up With the Times When Should I Come Off My Antidepressant? 6 Things to Consider 8 Survival Tips for the Spouse of a Terminally Ill Person How Well Do You Multitask Between the TV and the Computer? Woman Loses Sick-Leave Benefits for Depression Thanks to Facebook Pics Mental Health Year in Review: 2009 Melatonin As A "Greener" Sleep Aid? Subscribe to Our Weekly Newsletter

advertisement
Find a Therapist

Users Online: 2248
Join Us Now!
Local GuidesAll Guides
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
DC
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

#footer { height:220px; } #foot-mid { margin:0 0 0 40px; } Home • About Us • Advertise with Us • Contact Us
Privacy Policy • Terms of Use • Site Map • Disclaimer/Disclosure • Feeds